Book Value per Share: biogen.com (BIIB)
Biogen Inc. is shifting its focus from the multiple sclerosis market toward Alzheimer's disease therapy. On GURU.Markets, the book value per share visualizes this transition, where the 127.98 level reflects the current asset value. However, growth is constrained by costly R&D and the risk of clinical trial failures, as well as geopolitical complexities regarding raw material logistics and patent protection.
biogen.com - analytical breakdowns and key metrics (BIIB)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:Biogen Corp, BIIB
Investors use this parameter to determine the company's internal capital safety margin. The stable market moat of Biogen Inc. (BIIB) is maintained through patents for Alzheimer's and multiple sclerosis drugs. The current book value per share reflects the ratio of equity to the number of securities. This metric measures the actual value of net assets available upon business liquidation, making the asset fundamentally resilient during portfolio transformation.
Competitors of Biogen Inc. (BIIB)
Book Value per Share NBIX (Neurocrine Biosciences Inc)|RGC - Net Assets per Share|Axsome Therapeutics (AXSM) - Book Value per Share|ACAD (acadia-pharm.com) - Net Assets per Single Share|Net Assets per Single Share Xenon (XENE)|Equity per Share Viking Therapeutics Inc|Supernus Pharma - Book Value per Share|Net Asset Value per Share Catalyst Corp CPRX|Accounting Value per Share DNLI (Denali Therapeutics)|harmonybiosciences.com - Book Value per Share|Net Assets per Single Share Biohaven (BHVN)|AMLX: Accounting Value of a Share|Net Assets per Single Share TRVI|Praxis Corp (PRAX) - Net Asset Value per Share|Book Value per Share Anavex Life Sciences|Net Assets per Single Share ceribell.com|PRTA (Prothena Biosciences) - Book Value per Share|Net Assets per Share ALEC (alector.com)|ANNX: Net Assets per Single Share|Net Asset Value per Share Omeros Corp OMER|Book Value per Share NGNE|ACIU - Book Value of One Share|Book Value per Share VYGR|NMRA (Neumora) - Net Asset Value per Share|Net Assets per Single Share Scilex Holding Co. (SCLX)|Equity per Share Tevogen Bio Inc. (TVGN)|Alpha Cognition (ACOG) - Accounting Value per Share|Accounting Value of a Share Cognition Therapeutics Inc. (CGTX)|Book Value per Share IKT|Cassava Sciences Inc - Net Assets per Share|Assertio Therapeutics (ASRT) - Net Assets per Single Share|COYA - Equity per Share|VTGN (vistagen.com) - Book Value per Share|Accounting Value per Share Ovid Therapeutics|ABOS: Accounting Value per Share|Net Assets per Share CervoMed, Inc.|Book Value per Share Alterity Therapeutics (ATHE)|Net Assets per Single Share clene.com (CLNN)|Book Value per Share PEPG|Net Assets per Share Jupiter Neurosciences, Inc. JUNS|Book Value per Share RLMD (Relmada Therapeutics, Inc.)|ANVS - Net Assets per Share|gracetx.com (GRCE) - Book Value per Share|AIFF (Firefly Neuro) - Net Assets per Single Share|Net Assets per Single Share ANEW Medical (KLTO)|Equity per Share NeuroSense Therapeutics, Ltd.|Reviva Pharmaceuticals Holdings, Inc. - Book Value per Share|Net Asset Value per Share metaviatx.com MTVA|Accounting Value per Share NRXS (NeurAxis, Inc)|Helius Medical Technologies, Inc. - Book Value per Share|Net Assets per Single Share Passage Bio Corp (PASG)|NEUP: Accounting Value of a Share|Net Assets per Single Share NERV|Athira Pharma Inc (ATHA) - Net Asset Value per Share|Book Value per Share Addex Therapeutics, Ltd.|Net Assets per Single Share Alzamend|CYCN (Cyclerion Therapeutics) - Book Value per Share|Net Assets per Share PTIX (protagenic.com)|KTTA: Net Assets per Single Share|Net Asset Value per Share Cortigent Inc CRGT|Book Value per Share ATXI|BCLI - Book Value of One Share|Book Value per Share CARA|CHRO (chromocell.com) - Net Asset Value per Share|Net Assets per Single Share Eliem Therapeutics, Inc. (ELYM)|Equity per Share Intra-Cellular (ITCI)|Longboard Pharma (LBPH) - Accounting Value per Share|Accounting Value of a Share Marinus Pharma (MRNS)|Book Value per Share NKGN|neurobopharma.com - Net Assets per Share|Sage Therapeutics (SAGE) - Net Assets per Single Share|SNPX - Equity per Share|TRVN (Trevena, Inc) - Book Value per Share|Accounting Value per Share Vigil Neuroscience, Inc.|WENA: Accounting Value per Share|Net Assets per Share cerevel.com